3-Alpha Androstanediol Glucuronide
MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
Benzene Quantitative, Whole Blood
Ehrlichia Antibody, Western Blot
Gabapentin, Serum
Legionella pneumophilia antigen, DFA
Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine
Dyshormonogenetic goiter
Circulating Tumor Cells (CTC), Breast Cancer (Cellsearch®)
Biopsy, Kidney
LDS
Sign up
Log in
LDS
/
Medical Tests
/
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test
CPT
Access to
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
is restricted.
Sign up now